The low or borderline values observed in patients with moderate to severe uremia probably represent the result of their chronic illness and poor dietary intake. Such patients eventually undergo ...
Patients with uremia secondary to chronic kidney disease will generally require EPO replacement therapy for treatment or prevention of anemia; recombinant human EPO is, therefore, already a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback